 TORONTO, March 03, 2021 GLOBE NEWSWIRE -- Profound Medical Corp. NASDAQ:PROF; TSX:PRN Profound, a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, announced today the appointment of Cynthia Lavoie Ph.D., MBA, to its Board of Directors. 